Viva Biotech Completes $194 Million Hong Kong IPO; Trades Higher

Life Science

Takeda Divests Eye Drug to Novartis for $5.3 Billion

Life Science

Merck to Invest $1 Billion in Virginia Facility, Add 100 Jobs

Life Science

InnoCare Planning $250 Million IPO on Hong Kong Exchange

Life Science

VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer

Life Science

MORE Health Announces Strategic Collaboration with Beijing Henghe Hospital

Life Science

India’s Alembic Pharma Forms JV to Market Generics in China

Life Science

GeneQuantum Raises $15 Million for Novel ADC Drug Discovery

Life Science

China News Weekly 109 – China’s Meichen Partners Australian Firm to Grow Industrial Hemp

Life Science, Mining, Technology

Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics

Life Science

China’s Meichen Partners Australian Firm to Grow Industrial Hemp

Cannabis, Life Science

TAKE2 Health In-licenses IP for Nasopharyngeal Cancer Blood Test

Life Science

WuXi AppTec Acquires San Diego’s Pharmapace, a Biometrics CRO

Life Science

GW Pharma’s epilepsy drug meets main goal in late-stage trial

Cannabis, Life Science

FDA grants Jacobus Pharma approval for rare disease drug

Life Science